News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Quick, cheap genetic test could help prostate cancer treatment
Identifying which men with advanced prostate cancer will benefit from targeted treatments could be made easier with a quick and cost-effective test, researchers have found.
State of immune system linked to worse survival in biliary tract cancers
The state of the immune system in the area around a biliary tract cancer tumour may be a good indicator of whether the cancer is likely to return following surgery, researchers have found.
Overactive gene associated with more aggressive forms of bone marrow cancer myeloma
A gene which is overactive in some cases of myeloma has been linked, for the first time, with more aggressive forms of the disease.
Study splits incurable childhood brain tumours into 10 new diseases
Scientists have found that deadly childhood brain tumours are actually 10 different diseases that should each be diagnosed and treated based on their specific genetic faults.
No evidence for genetic link between height and testicular cancer
There is no evidence being tall causes an increased risk of testicular cancer, according to a new genetic analysis of more than 24,000 men.
Pioneering ‘precision’ radiotherapy boosts prostate cancer survival
A high-tech form of radiotherapy that shapes radiation beams to tumours can dramatically improve outcomes for patients with prostate cancer, long-term clinical trial results show.
New treatment approach for rare type of ‘triple negative’ breast cancers identified
Leading scientists funded by Breast Cancer Now have identified a potential new treatment approach for some ‘triple negative’ breast cancers (TNBCs).
Blood test could predict response of HPV-positive head and neck cancer to treatment
Researchers have developed a blood test that can detect whether patients with a type of locally advanced (non-metastatic) head and neck cancer have residual tumours after chemotherapy and radiotherapy.
ICR reacts to decision to make the immunotherapy nivolumab available on the Cancer Drugs Fund for non-small cell lung cancers
The ICR responds to the announcement by NICE that the immunotherapy nivolumab (Opdivo) will now be made available on the Cancer Drugs Fund for non-small cell lung cancers.
Whole-body scans benefit people with highest inherited cancer risk
People with a gene mutation that confers a very high risk of cancer would benefit from a whole-body MRI scan to detect the disease early, a new study reports.
Testing metabolites in blood predicts success of skin cancer treatment
Testing for a panel of metabolites in the blood can pick out which patients are likely to respond to a drug for skin cancer, new research reports.
The ICR pays tribute to researcher James Morden
The Institute of Cancer Research, London, has paid tribute to the life of James Morden, a senior medical statistician in the Clinical Trials and Statistics Unit (ICR-CTSU), who was tragically killed at the weekend.
